All Facilities , From 2026-08-31 - 2026-09-15
Susceptibility isolates
231
AST results tested
2,243
Overall susceptibility
50.4%
Highest rate
Voriconazole (100.0%)
n = 231 Number of Isolates
All Specimens All Organisms
n = 231 Number of Isolates
All Specimens All Organisms
| Antibiotic | Total Tested | Number Susceptibility | % Susceptibility |
|---|---|---|---|
| Voriconazole | 3 | 3 | 100.0 |
| Moxifloxacin | 9 | 9 | 100.0 |
| Tigecycline | 5 | 5 | 100.0 |
| Teicoplanin | 6 | 6 | 100.0 |
| Minocycline | 3 | 3 | 100.0 |
| Colistin | 2 | 2 | 100.0 |
| Caspofungin | 3 | 3 | 100.0 |
| Fluconazole | 4 | 4 | 100.0 |
| Flucytosine | 3 | 3 | 100.0 |
| Micafungin | 3 | 3 | 100.0 |
| Vancomycin | 48 | 46 | 95.8 |
| Meropenem | 95 | 87 | 91.6 |
| Linezolid | 37 | 33 | 89.2 |
| Imipenem | 102 | 85 | 83.3 |
| Amikacin | 57 | 46 | 80.7 |
| Nitrofurantoin | 80 | 62 | 77.5 |
| Rifampin | 4 | 3 | 75.0 |
| Doxycline | 4 | 3 | 75.0 |
| Levofloxacin | 64 | 46 | 71.9 |
| Doxycycline | 16 | 11 | 68.8 |
| Piperacillin/Tazobactam | 129 | 86 | 66.7 |
| Clindamycin | 55 | 36 | 65.5 |
| Chloramphenicol | 86 | 51 | 59.3 |
| Gentamicin | 203 | 98 | 48.3 |
| Ciprofloxacin | 163 | 74 | 45.4 |
| Azithromycin | 9 | 4 | 44.4 |
| Amoxicillin/ Clavulanic acid | 61 | 27 | 44.3 |
| Cefoxitin | 51 | 22 | 43.1 |
| Tobramycin | 7 | 3 | 42.9 |
| Ceftazidime | 130 | 53 | 40.8 |
| Cefepime | 90 | 34 | 37.8 |
| Tetracycline | 65 | 24 | 36.9 |
| Erythromycin | 54 | 19 | 35.2 |
| Nalidixic acid | 34 | 11 | 32.4 |
| Trimethoprim/Sulfamethoxazole | 140 | 45 | 32.1 |
| Cefotaxime | 45 | 14 | 31.1 |
| Trimethoprim | 27 | 7 | 25.9 |
| Cefuroxime | 81 | 20 | 24.7 |
| Ceftriaxone | 131 | 28 | 21.4 |
| Penicillin G | 18 | 3 | 16.7 |
| Ampicillin/ Sulbactam | 14 | 2 | 14.3 |
| Aztreonam | 19 | 2 | 10.5 |
| Ampicillin | 57 | 5 | 8.8 |